Jared L. Antevil

Dr. Jared L. Antevil

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2022 in Surgical Clinics of North America
Verified
Journal Article
Closed access
JDJohn P. Duggan
John P. Duggan
APAlex S. Peters
Alex S. Peters
GTGregory D. Trachiotis
Gregory D. Trachiotis
JAJared L. Antevil
Jared L. Antevil

4 June 2022 in Surgical Clinics of North America
Verified
Journal Article
Closed access
APAlex S. Peters
Alex S. Peters
JDJohn P. Duggan
John P. Duggan
GTGregory D. Trachiotis
Gregory D. Trachiotis
JAJared L. Antevil
Jared L. Antevil

1 October 2022 in JAMA Oncology
Verified
Journal Article
Open access
PDF file
CFCharles Faselis
Charles Faselis
JNJoel Anthony Nations
Joel Anthony Nations
CMCharity J. Morgan
Charity J. Morgan
JAJared L. Antevil
Jared L. Antevil
JRJeffrey M. Roseman
Jeffrey M. Roseman
AAAli Ahmed
Ali Ahmed
Importance: The US Preventive Services Task Force does not recommend annual lung cancer screening with low-dose computed tomography (LDCT) for adults aged 50 to 80 years who are former smokers with 20 or more pack-years of smoking who quit 15 or more years ago or current smokers with less than 20 pack-years of smoking.Objective: To determine the risk of lung cancer in older smokers for whom LDCT screening is not recommended.Design, Settings, and Participants: This cohort study used the Cardiovascular Health Study (CHS) data sets obtained from the National Heart, Lung and Blood Institute, which also sponsored the study. The CHS enrolled 5888 community-dwelling individuals aged 65 years and older in the US from June 1989 to June 1993 and collected extensive baseline data on smoking history. The current analysis was restricted to 4279 individuals free of cancer who had baseline data on pack-year smoking history and duration of smoking cessation. The current analysis was conducted from January 7, 2022, to May 25, 2022.Exposures: Current and prior tobacco use.Main Outcomes and Measures: Incident lung cancer during a median (IQR) of 13.3 (7.9-18.8) years of follow-up (range, 0 to 22.6) through December 31, 2011. A Fine-Gray subdistribution hazard model was used to estimate incidence of lung cancer in the presence of competing risk of death. Cox cause-specific hazard regression models were used to estimate hazard ratios (HRs) and 95% CIs for incident lung cancer.Results: There were 4279 CHS participants (mean [SD] age, 72.8 [5.6] years; 2450 [57.3%] women; 663 [15.5%] African American, 3585 [83.8%] White, and 31 [0.7%] of other race or ethnicity) included in the current analysis. Among the 861 nonheavy smokers (<20 pack-years), the median (IQR) pack-year smoking history was 7.6 (3.3-13.5) pack-years for the 615 former smokers with 15 or more years of smoking cessation, 10.0 (5.3-14.9) pack-years for the 146 former smokers with less than 15 years of smoking cessation, and 11.4 (7.3-14.4) pack-years for the 100 current smokers. Among the 1445 heavy smokers (20 or more pack-years), the median (IQR) pack-year smoking history was 34.8 (26.3-48.0) pack-years for the 516 former smokers with 15 or more years of smoking cessation, 48.0 (35.0-70.0) pack-years for the 497 former smokers with less than 15 years of smoking cessation, and 48.8 (31.6-57.0) pack-years for the 432 current smokers. Incident lung cancer occurred in 10 of 1973 never smokers (0.5%), 5 of 100 current smokers with less than 20 pack-years of smoking (5.0%), and 26 of 516 former smokers with 20 or more pack-years of smoking with 15 or more years of smoking cessation (5.0%). Compared with never smokers, cause-specific HRs for incident lung cancer in the 2 groups for whom LDCT is not recommended were 10.54 (95% CI, 3.60-30.83) for the current nonheavy smokers and 11.19 (95% CI, 5.40-23.21) for the former smokers with 15 or more years of smoking cessation; age, sex, and race–adjusted HRs were 10.06 (95% CI, 3.41-29.70) for the current nonheavy smokers and 10.22 (4.86-21.50) for the former smokers with 15 or more years of smoking cessation compared with never smokers.Conclusions and Relevance: The findings of this cohort study suggest that there is a high risk of lung cancer among smokers for whom LDCT screening is not recommended, suggesting that prediction models are needed to identify high-risk subsets of these smokers for screening.

27 May 2021 in The Thoracic and Cardiovascular Surgeon
Verified
Journal Article
Closed access
PDF file
MNMichael A. Napolitano
Michael A. Napolitano
ASAndrew D. Sparks
Andrew D. Sparks
GWGregor Werba
Gregor Werba
EREthan S. Rosenfeld
Ethan S. Rosenfeld
JAJared L. Antevil
Jared L. Antevil
GTGregory D. Trachiotis
Gregory D. Trachiotis
Background Video-assisted thoracoscopic surgery (VATS) offers reduced morbidity compared with open thoracotomy (OT) for pulmonary surgery. The use of VATS over time has increased, but at a modest rate in civilian populations. This study examines temporal trends in VATS use and compares outcomes between VATS and OT in the Veterans Health Administration (VHA). Methods Patients who underwent pulmonary surgery (wedge or segmental resection, lobectomy, or pneumonectomy) at Veterans Affairs centers from 2008 to 2018 were retrospectively identified using the Veterans Affairs Surgical Quality Improvement Project database. The cohort was divided into OT and VATS and propensity score matched, taking into account the type of pulmonary resection, preoperative diagnosis, and comorbidities. Thirty-day postoperative outcomes were compared. The prevalence of VATS use and respective complications over time was also analyzed. Results A total of 16,895 patients were identified, with 5,748 per group after propensity matching. VATS had significantly lower rates of morbidity and a 2-day reduction in hospital stay. Whereas 76% of lung resections were performed open in 2008, nearly 70% of procedures were performed using VATS in 2018. While VATS was associated with an 8% lower rate of major complications compared with thoracotomy in 2008, patients undergoing VATS lung resection in 2018 had a 58% lower rate of complications (p < 0.001). Conclusions VATS utilization at VHA centers has become the predominant technique used for pulmonary surgeries over time. OT patients had more complications and longer hospital stays compared with VATS. Over the study period, VATS patients had increasingly lower complication rates compared with open surgery.

18 March 2022 in Journal of Surgical Research
Verified
Journal Article
Closed access
PDF file
THTimothy J. Holleran
Timothy J. Holleran
MNMichael A. Napolitano
Michael A. Napolitano
ASAndrew D. Sparks
Andrew D. Sparks
JAJared L. Antevil
Jared L. Antevil
FBFredrick J. Brody
Fredrick J. Brody
GTGregory D. Trachiotis
Gregory D. Trachiotis

31 January 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JDJohn Duggan
John Duggan
APAlex Peters
Alex Peters
JAJared L. Antevil
Jared L. Antevil
CFCharles Faselis
Charles Faselis
ISImmanuel Samuel
Immanuel Samuel
GTGregory D. Trachiotis
Gregory D. Trachiotis
The aim of this study was to evaluate the association between cardiorespiratory fitness (CRF) and long-term survival in United States (US) Veterans undergoing CABG. We identified 14,550 US Veterans who underwent CABG at least six months after completing a symptom-limited exercise treadmill test (ETT) with no evidence of cardiovascular disease. During a mean follow-up period of 10.0 ± 5.4 years, 6502 (43.0%) died. To assess the association between CRF and risk of mortality, we formed the following five fitness categories based on peak workload achieved (metabolic equivalents or METs) prior to CABG: Least-Fit (4.3 ± 1.0 METs (n = 4722)), Low-Fit (6.8 ± 0.9 METs (n = 3788)), Moderate-Fit (8.3 ± 1.1 METs (n = 2608)), Fit (10.2 ± 0.8 METs (n = 2613)), and High-Fit (13.0 ± 1.5 METs (n = 819)). Cox proportional hazard models were used to calculate risk across CRF categories. The models were adjusted for age, body mass index, race, cardiovascular disease, percutaneous coronary intervention prior to ETT, cardiovascular medications, and cardiovascular disease risk factors. P-values < 0.05 using two-sided tests were considered statistically significant. The association between cardiorespiratory fitness and mortality was inverse and graded. For every 1-MET increase in exercise capacity, the mortality risk was 11% lower (HR = 0.89; CI: 0.88–0.90; p < 0.001). When compared to the Least-Fit category (referent), mortality risk was 22% lower in Low-Fit individuals (HR = 0.78; CI: 0.73–0.82; p < 0.001), 31% lower in Moderate-Fit individuals (HR = 0.69; CI: 0.64–0.74; p < 0.001), 52% lower in Fit individuals (HR = 0.48; CI: 0.44–0.52; p < 0.001), and 66% lower in High-Fit individuals (HR = 0.34; CI: 0.29–0.40; p < 0.001). Cardiorespiratory fitness is inversely and independently associated with long-term mortality after CABG in Veterans referred for exercise testing.